How Can We Help You?

Quick Info:

Find a Doctor Specialties (800) 213-3284

Go To Home PageBack

Pancreatic Cancer Trails

Select Clinical Trial

Boston Biomedical Inc. CanStem 111P – Pancreatic

  • Study of Napabucasin Plus Nab-Paclitaxel With Gemcitabine in Adult Patients With Metastatic Pancreatic Adenocarcinoma.
  • Patient Population:  18 years and older;  metastatic pancreatic ductal adenocarcinoma; must not have previously received chemotherapy or any investigational agent; has one or more metastatic tumors evaluable by CT scan with contrast (or MRI, if patient is allergic to CT contrast media); life-expectancy of > 12 weeks.

SWOG 1513

  • FOLFIRI or Modified FOLFIRI and Veliparib as Second Line Therapy in Treating Patients With Metastatic Pancreatic Cancer
  • Men or women, ages 18 or older, diagnosed with metastatic pancreatic cancer.
  • For additional criteria, call our Clinical Trials office at (910) 715-2200.
Clara McLean House
Make a Donation
News & Events